Category: MassDevice.com Earnings Roundup
Spectranetics says it plans to boost its R&D spend on the Stellarex drug-eluting balloon it bought from Covidien.
Share prices tick up for C.R. Bard after it reports a 1st-quarter earnings beat.
C.R. Bard (NYSE:BCR) shares gained today after the medical products giant reported 1st-quarter earnings that topped expectations on Wall Street, despite a poor quarterly comparison for its Lutonix drug-eluting balloon.
Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-generation Sapien 3 replacement heart valve this year.
Baxter International reports 1st-quarter results that top its own and Wall Street's sales & earnings expectations.
Investors bid shares of Baxter (NYSE:BAX) up this morning after the healthcare giant reported sales and earnings that beat expectations on Wall Street and its own prior guidance, despite declines for both numbers.
Abbott's 1st-quarter profits top expectations as sales of its branded generic drugs jump.
St. Jude Medical's 1st-quarter earnings top both its own guidance and Wall Street's outlook, prompting the medical device company to boost its 2015 sales forecast.
Stryker's 1st-quarter profits surge 220% on a strong comparison with Q1 2014, when recall expenses took $344 million from the bottom line.
Stryker (NYSE:SYK) yesterday topped Wall Street's earning forecast with its 1st-quarter results, buoyed by a strong comparison with Q1 2014.